1. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. (eds) (1975–2015) SEER cancer statistics review. National Cancer Institute, Bethesda
2. Le Guyader-Peyrou S, Defossez G, Dantony E, Mounier M, Cornet E, Uhry Z, et al (2019) Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. In: Hémopathies malignes. Étude à partir des registres des cancers du réseau Francim, Vol 2. Santé publique France, Saint-Maurice (Fra), p. 169
3. Monnereau A, Uhry Z, Bossard N, Cowppli-Bony A, Voirin N, Delafosse P et al (2016) Survival of cancer patients in metropolitan France 1989–2013. In: Part 2—Hematological malignancies. Santé publique France, Saint-Maurice (Fra), p. 144
4. Birmann BM, Andreotti G, De Roos AJ, Camp NJ, Chiu BCH, Spinelli JJ et al (2017) Young adult and usual adult body mass index and multiple myeloma risk: a pooled analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomark Prev 26(6):876–885
5. Schinasi LH, Brown EE, Camp NJ, Wang S, Hofmann JN, Chiu BC et al (2016) Multiple myeloma and family history of lymphohaematopoietic cancers: results from the International Multiple Myeloma Consortium. Br J Haematol 175(1):87–101